Jonathan Friedlander is a PhD scientist turned investor who earned his doctorate in cell biology from the University of Cambridge and an MBA from Harvard Business School, then worked as an associate at Flagship Pioneering creating new biotech companies before joining Digitalis Ventures. He co-authors Digitalis's "Notes on Engineering Health" essay series, which explores healthcare system mechanics like payers, pharmacy benefit managers, and providers alongside big-picture health themes such as women's health, aging, and environmental health. Jonathan Friedlander is a PhD scientist turned investor who earned his doctorate in cell biology from the University of Cambridge and an MBA from Harvard Business School, then worked as an associate at Flagship Pioneering creating new biotech companies before joining Digitalis Ventures. He co-authors Digitalis's "Notes on Engineering Health" essay series, which explores healthcare system mechanics like payers, pharmacy benefit managers, and providers alongside big-picture health themes such as women's health, aging, and environmental health.